Advances in PH Journal
Advances in Pulmonary Hypertension Autumn 2009 (Vol 8, No 3)
- Editor's Memo
It is with great excitement that I introduce the Fall 2009 issue of Advances, devoted to pulmonary hypertension in the setting of lung or respiratory disease (or WHO Diagnostic Group III). Dr Omar Minai has done an outstanding job of coordinating the issue and contri-buting one of the articles.
- Guest Editor's Memo
Translating Evidence into Clinical Practice
- Profiles in Pulmonary Hypertension
Emmanuel Weitzenblum, MD, Pioneer in Right Heart Catheterization
- Ask the Expert
Are there any data indicating that medication such as bosentan or RevatioTM (sildenafil citrate) or any other medication helps secondary pulmonary hypertension for a patient with mitral regurgitation, obstructive sleep apnea, and pulmonary artery systolic pressure
of 85 mm Hg?
- Article Reviews
Summaries and commentaries from the section editors present a clinical context for practitioners' application of recently published research relevant to care of patients with pulmonary hypertension.
- Advances in Pulmonary Hypertension CME Section
- Pulmonary Hypertension in Obstructive Sleep Apnea Syndrome
Cor pulmonale has a well-described association with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and interstitial lung diseases.
- Diagnosis and Management of Pulmonary Hypertension Associated with Pulmonary Fibrosis
Pulmonary fibrosis is a term often used to refer to a group of interstitial lung diseases (ILD) that are characterized by the inappropriate deposition of collagen, fibrocytes, and inflammatory cells in the lung interstitium.
- Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease: Diagnosis and Management
Pulmonary hypertension (PH) related to chronic obstructive pulmonary disease (COPD) is part of Group III, as defined by the World Health Organization (WHO), which comprises the group of PH associated with lung disorders and hypoxemia, such as COPD, interstitial lung disease, sleep disordered breathing, and high altitude PH.
- Pulmonary Hypertension Associated with Sarcoidosis
- CME Self-Assessment Examination
- Pulmonary Hypertension Roundtable
PH in Patients with Lung Disease and Hypoxia
- Clinical Trials Update
In this issue we highlight 2 multicenter trials that recently led to FDA approval for 2 new PAH therapies: PHIRST-1 and TRIUMPH-1.
- PHRN Corner
Choosing a Home Oxygen System